Literature DB >> 11853032

Osteoporosis in women with spinal cord injuries.

S M Ott1.   

Abstract

Decreased bone density and increased fracture risk are seen in patients with SCI. The bone resorption rate is markedly increased. Hypercalciuria, low PTH, and low 1,25 (OH)2 vitamin D are commonly seen. Bed-rest studies show similar findings, but of lesser magnitude. Therapies to treat or prevent osteoporosis include optimal nutrition (with care to avoid exacerbating hypercalciuria). Weight-bearing or functional electrical stimulation cycle ergometry may prevent some of the bone loss, especially in acutely injured patients. Estrogen should be considered in postmenopausal or amenorrheic women, but not if they are at high risk of thromboembolism. More research on effects of estrogen is needed in this population. Bisphosphonates may also help prevent the acute bone loss; oral routes must not be used in recumbent patients. Thiazides could be useful as adjunct therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11853032

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  3 in total

1.  Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil.

Authors:  Melissa Orlandin Premaor; Gustavo Vasconcelos Alves; Ligia Beatriz Crossetti; Tania Weber Furlanetto
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

2.  Treatment of immobilization hypercalciuria using weekly alendronate in two quadriplegic patients.

Authors:  Ayce Atalay; Nur Turhan
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

3.  Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review.

Authors:  Nour Zleik; Frances Weaver; Robert L Harmon; Brian Le; Reshmitha Radhakrishnan; Wanda D Jirau-Rosaly; B Catharine Craven; Mattie Raiford; Jennifer N Hill; Bella Etingen; Marylou Guihan; Michael H Heggeness; Cara Ray; Laura Carbone
Journal:  J Spinal Cord Med       Date:  2018-05-10       Impact factor: 1.985

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.